Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : INCR - Incara Pharmaceuticals Corporation -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (7)	7/24/1999 10:37:00 AM
From: JEB	Read Replies (1) \| Respond to of 13

Good bet...you win! I also know someone who has Crohn's and I am monitoring that INCR study intently. I will let you know what I find as it progresses. Did you see the BEXTRA phase III news? INCR owns 35% of this project. BEXTRA is for Congestive Heart Failure (CHF). CHF is the only cardiovascular disease growing in the number of incidence reports in the US. BTW - thanks for dropping in! You've saved me from appearing schizophrenic. For my next posts, I was planning to argue with myself...hmmm...I still might! Good trading Jim, JEB

To: Jim Bishop who wrote (7)	10/26/1999 9:33:00 PM
From: Jon	Respond to of 13

Jim, I don't know what its worth, but I have been adviced to buy this stock in the last few days. My advice came from friends of friends, and though its not very verifyiable, I still will put a few dollars in this one. For what I can figure out there is 1.6 mill shares in the float......hope that is right. The story I hear is that there is three patents coming out and the results from testing is very good. But this is only rumors and You have totake it for its worth. By the way I love fly fishing too and cant wait for my next trip into the wilderness to be with nature and catch and release a few trout All the best to you and may prosperity be with us all Jon